Custom mRNA vaccine aims to stop Cancer's return after surgery
⭐️ VACCINE ⭐️
Recruiting now
This early-phase study tests a personalized mRNA cancer vaccine (XH001) given alongside standard treatment after surgery for people with high-risk solid tumors (bile duct, gallbladder, pancreatic, liver, or stomach cancer). The main goals are to check safety and see if the vaccin…
Phase: PHASE1 • Sponsor: Shenzhen Xinhe Biomedical • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 02:00 UTC